Drugs / PRS CK STORM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06684379 | Oct 2024 → Oct 2026 expected | COVID-19, acute respiratory distress syndrome, autoinflammatory syndrome, influenza +1 | PEACHES BIOTECH | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRS CK STORM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06684379 ↗ |
| Route | Intravenous | “via IV infusion” NCT06684379 ↗ |